CIK 0001677077 · <br>Emerging growth company
Alzamend Neuro, Inc.
Sign in to watch- Ticker
- ALZN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Apr 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811822909
- Phone
- 844-722-6333
- Business address
- 480 PEACHTREE ROAD NE, SECOND FLOOR, SUITE 103, ATLANTA, GA, 30326
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,116
- in 1 filing
Net −$3,116. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-15 | Woo Andrew H. Director | Grant or award · Restricted Stock Grant | +100,000 | 100,000 | ||
| 2021-06-15 | Woo Andrew H. Director | Grant or award · Stock Options (Right to Buy) | +300,000 | 300,000 | ||
| 2021-06-15 | AULT MILTON C III 10% owner | Purchase | +1,400 | $12.72 | $18K | 5,158,455 |
| 2021-06-15 | AULT MILTON C III 10% owner | Purchase | +2,000,000 | $5.00 | $10.0M | 5,094,555 |
Page 15 of 15 · 284 trades